首页> 美国卫生研究院文献>Acta Pharmaceutica Sinica. B >Updated developments on molecular imaging and therapeutic strategies directed against necrosis
【2h】

Updated developments on molecular imaging and therapeutic strategies directed against necrosis

机译:针对坏死的分子影像学和治疗策略的最新进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell death plays important roles in living organisms and is a hallmark of numerous disorders such as cardiovascular diseases, sepsis and acute pancreatitis. Moreover, cell death also plays a pivotal role in the treatment of certain diseases, for example, cancer. Noninvasive visualization of cell death contributes to gained insight into diseases, development of individualized treatment plans, evaluation of treatment responses, and prediction of patient prognosis. On the other hand, cell death can also be targeted for the treatment of diseases. Although there are many ways for a cell to die, only apoptosis and necrosis have been extensively studied in terms of cell death related theranostics. This review mainly focuses on molecular imaging and therapeutic strategies directed against necrosis. Necrosis shares common morphological characteristics including the rupture of cell membrane integrity and release of cellular contents, which provide potential biomarkers for visualization of necrosis and necrosis targeted therapy. In the present review, we summarize the updated joint efforts to develop molecular imaging probes and therapeutic strategies targeting the biomarkers exposed by necrotic cells. Moreover, we also discuss the challenges in developing necrosis imaging probes and propose several biomarkers of necrosis that deserve to be explored in future imaging and therapy research.
机译:细胞死亡在生物体中起重要作用,并且是许多疾病(例如心血管疾病,败血症和急性胰腺炎)的标志。此外,细胞死亡在某些疾病例如癌症的治疗中也起关键作用。细胞死亡的无创可视化有助于深入了解疾病,制定个性化治疗计划,评估治疗反应以及预测患者的预后。另一方面,细胞死亡也可以靶向治疗疾病。尽管细胞死亡的方法有很多,但是就细胞死亡相关的治疗学而言,仅对凋亡和坏死进行了广泛的研究。这项审查主要侧重于针对坏死的分子成像和治疗策略。坏死具有共同的形态特征,包括细胞膜完整性破裂和细胞内含物释放,这为可视化坏死和靶向坏死治疗提供了潜在的生物标记。在当前的审查中,我们总结了更新的共同努力,以开发针对坏死细胞暴露的生物标志物的分子成像探针和治疗策略。此外,我们还讨论了开发坏死成像探针的挑战,并提出了一些坏死生物标志物,值得在未来的成像和治疗研究中加以探讨。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号